Основная статистика
| CIK | 1457543 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to CareFusion Corporation
SEC Filings (Chronological Order)
На этой странице представлен полный хронологический список документов SEC, за исключением документов о собственности, которые мы предоставляем в других местах.
| April 27, 2015 |
Form 15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-34273 CAREFUSION CORPORATION (Exact name of registrant as specif |
|
| March 27, 2015 |
Form 15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-34273 CAREFUSION CORPORATION (Exact name of registrant as specif |
|
| March 17, 2015 |
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION CAREFUSION CORPORATION EX-3.1 Exhibit 3.1 EXHIBIT A AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CAREFUSION CORPORATION FIRST: The name of the Corporation is CAREFUSION CORPORATION. SECOND: The address of the registered office of the Corporation in the State of Delaware is 1209 Orange Street, Wilmington, County of New Castle, 19801. The name of its registered agent at that address is The Corporation Trust Compan |
|
| March 17, 2015 |
CFN POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 As filed with the Securities and Exchange Commission on March 17, 2015 Registration No. |
|
| March 17, 2015 |
BECTON DICKINSON COMPLETES ACQUISITION OF CAREFUSION EX-99.1 Exhibit 99.1 1 Becton Drive Franklin Lakes, NJ 07417 www.bd.com News Release Investors: Monique N. Dolecki 201-847-5378 [email protected] Media: Kristen Cardillo (858) 617-2317 [email protected] BECTON DICKINSON COMPLETES ACQUISITION OF CAREFUSION Franklin Lakes, NJ (March 17, 2015) ? Becton, Dickinson and Company (NYSE: BDX) (?BD?) today announced that it completed its a |
|
| March 17, 2015 |
CFN POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 Post-Effective Amendment No. 1 to Form S-8 As filed with the Securities and Exchange Commission on March 17, 2015. Registration No. 333-161615 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 To Form S-8 Registration Statement No. 333-161615 UNDER THE SECURITIES ACT OF 1933 CAREFUSION CORPORATION (Exact Name of Registrant as Specified in Its Ch |
|
| March 17, 2015 |
EX-3.2 Exhibit 3.2 AMENDED AND RESTATED BY-LAWS OF CAREFUSION CORPORATION A Delaware Corporation Effective March 17, 2015 TABLE OF CONTENTS Page ARTICLE I OFFICES Section 1.1 Registered Office 1 Section 1.2 Other Offices 1 ARTICLE II MEETINGS OF STOCKHOLDERS Section 2.1 Place of Meetings 2 Section 2.2 Annual Meetings 2 Section 2.3 Special Meetings 2 Section 2.4 Notice 3 Section 2.5 Adjournments 3 |
|
| March 17, 2015 |
NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on March 30, 2015, pursuant to the provisions of Rule 12d2-2 (a). |
|
| March 17, 2015 |
8-K 1 d890298d8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 17, 2015 CAREFUSION CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-34273 26-4123274 (State or Other Jurisdiction of Inc |
|
| March 17, 2015 |
CFN POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 Post-Effective Amendment No. 1 to Form S-3 As filed with the Securities and Exchange Commission on March 17, 2015 Registration No. 333-195887 Registration No. 333-195921 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to Form S-3 Registration Statement No. 333-195887 Post-Effective Amendment No. 1 to Form S-3 Registration Statement No. 333-195 |
|
| March 17, 2015 |
CFN POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 Post-Effective Amendment No. 1 to Form S-8 As filed with the Securities and Exchange Commission on March 17, 2015. Registration No. 333-161611 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 To Form S-8 Registration Statement No. 333-161611 UNDER THE SECURITIES ACT OF 1933 CAREFUSION CORPORATION (Exact Name of Registrant as Specified in Its Ch |
|
| March 13, 2015 |
EX-99.1 Exhibit 99.1 BD Contacts: Media: Abigail Cardona 201-847-4605 [email protected] Investors: Monique N. Dolecki 201-847-5378 [email protected] CareFusion Contacts: Media: Kristen Cardillo (858) 617-2317 [email protected] Investors: Tristan Ribar (858) 617-1476 [email protected] EUROPEAN COMMISSION CLEARS BD ACQUISITION OF CAREFUSION Clearance Completes Requir |
|
| March 13, 2015 |
Financial Statements and Exhibits, Other Events 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 13, 2015 CAREFUSION CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-34273 26-4123274 (State or Other Jurisdiction of Incorporation) (Commissi |
|
| March 13, 2015 |
EX-99.1 2 d891528dex991.htm EX-99.1 Exhibit 99.1 BD Contacts: Media: Abigail Cardona 201-847-4605 [email protected] Investors: Monique N. Dolecki 201-847-5378 [email protected] CareFusion Contacts: Media: Kristen Cardillo (858) 617-2317 [email protected] Investors: Tristan Ribar (858) 617-1476 [email protected] EUROPEAN COMMISSION CLEARS BD ACQUISITION OF CAREFUSIO |
|
| March 13, 2015 |
Becton Dickinson 8-K (Prospectus) 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of the earliest event reported): March 13, 2015 BECTON, DICKINSON AND COMPANY (Exact name of registrant as specified in its charter) New Jersey 001-4802 22-0760120 (State or other jurisdiction of incorporatio |
|
| February 12, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ) CAREFUSION CORP (Name of Issuer) COMMON STOCK (Title of Class of Securities) 14170T101 (CUSIP Number) December 31, 2014 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is fi |
|
| February 10, 2015 |
CFN / CareFusion Corporation / VANGUARD GROUP INC Passive Investment carefusioncorp.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 3 )* Name of issuer: CareFusion Corp Title of Class of Securities: Common Stock CUSIP Number: 14170T101 Date of Event Which Requires Filing of this Statement: December 31, 2014 Check the appropriate box to de |
|
| February 6, 2015 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2014 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-34273 CareFusion Corporation (Exact nam |
|
| February 5, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 5, 2015 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 (Commission |
|
| February 5, 2015 |
EX-99.1 2 ex991fy15q2.htm NEWS RELEASE Exhibit 99.1 3750 Torrey View Ct San Diego, CA 92130 www.carefusion.com FOR IMMEDIATE RELEASE Contacts: Media: Kristen Cardillo (858) 617-2317 [email protected] Investors: Jim Mazzola (858) 617-1203 [email protected] CAREFUSION REPORTS SECOND QUARTER FISCAL 2015 RESULTS • Revenue increased 16 percent to $1.07 billion • GAAP diluted earn |
|
| January 21, 2015 |
Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 21, 2015 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 (Commis |
|
| January 21, 2015 |
CAREFUSION STOCKHOLDERS APPROVE PROPOSED MERGER WITH BECTON, DICKINSON EX-99.1 2 d855918dex991.htm EX-99.1 Exhibit 99.1 BD Contacts: Monique N. Dolecki, Investor Relations 201-847-5378 [email protected] Abigail Cardona 201-847-4605 [email protected] CareFusion Contacts: Media: Kristen Cardillo (858) 617-2317 [email protected] Investors: Tristan Ribar (858) 617-1476 [email protected] CAREFUSION STOCKHOLDERS APPROVE PROPOSED MERGER WITH |
|
| January 21, 2015 |
CFN / CareFusion Corporation 425 - Merger Prospectus - 8-K 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 21, 2015 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 (Commis |
|
| January 21, 2015 |
CAREFUSION STOCKHOLDERS APPROVE PROPOSED MERGER WITH BECTON, DICKINSON EX-99.1 2 d855918dex991.htm EX-99.1 Exhibit 99.1 BD Contacts: Monique N. Dolecki, Investor Relations 201-847-5378 [email protected] Abigail Cardona 201-847-4605 [email protected] CareFusion Contacts: Media: Kristen Cardillo (858) 617-2317 [email protected] Investors: Tristan Ribar (858) 617-1476 [email protected] CAREFUSION STOCKHOLDERS APPROVE PROPOSED MERGER WITH |
|
| January 15, 2015 |
BDX / Becton Dickinson & Co. 425 - Merger Prospectus - 425 425 FILED BY BECTON, DICKINSON AND COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14A-12 OF THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: CAREFUSION CORP COMMISSION FILE NO. |
|
| January 14, 2015 |
BDX / Becton Dickinson & Co. 425 - Merger Prospectus - 425 425 FILED BY BECTON, DICKINSON AND COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14A-12 OF THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: CAREFUSION CORP COMMISSION FILE NO. |
|
| January 5, 2015 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 5, 2015 (December 31, 2014) CAREFUSION CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-34273 26-4123274 (State or Other Jurisdiction of Inc |
|
| January 5, 2015 |
CFN / CareFusion Corporation 425 - Merger Prospectus - 8-K 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 5, 2015 (December 31, 2014) CAREFUSION CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-34273 26-4123274 (State or Other Jurisdiction of Inc |
|
| January 5, 2015 |
CFN / CareFusion Corporation DEFA14A - - DEFINITIVE ADDITIONAL MATERIALS Definitive Additional Materials UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| January 5, 2015 |
BDX / Becton Dickinson & Co. 425 - Merger Prospectus - 8-K 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of the earliest event reported): January 5, 2015 (December 31, 2014) BECTON, DICKINSON AND COMPANY (Exact name of registrant as specified in its charter) New Jersey 001-4802 22-0760120 (State or other jurisdi |
|
| December 19, 2014 |
EX-10.1 2 d840459dex101.htm EX-10.1 Exhibit 10.1 U.S. $1,000,000,000 364-DAY TERM LOAN AGREEMENT Dated as of December 19, 2014 Among BECTON, DICKINSON AND COMPANY as Borrower and THE LENDERS party hereto GOLDMAN SACHS BANK USA as Administrative Agent GOLDMAN SACHS BANK USA and J.P. MORGAN SECURITIES LLC as Joint Lead Arrangers and Joint Bookrunners JPMORGAN CHASE BANK, N.A. as Syndication Agent an |
|
| December 19, 2014 |
CFN / CareFusion Corporation DEFM14A - - DEFINITIVE PROXY STATEMENT Definitive Proxy Statement Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| December 19, 2014 |
BDX / Becton Dickinson & Co. 425 - Merger Prospectus - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 19, 2014 BECTON, DICKINSON AND COMPANY (Exact name of registrant as specified in its charter) New Jersey 001-4802 22-0760120 (State or Other Jurisdiction of Incorpor |
|
| December 8, 2014 |
CFN / CareFusion Corporation 425 - Merger Prospectus - 425 425 FILED BY CAREFUSION CORP. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14A-12 OF THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: CAREFUSION CORP COMMISSION FILE NO. 333-199830 CareFusion Corporation made the following communication available to its employees on December 8, 2014: Dec. 8, 2014 Joan Stafslien EVP and General Counsel Jason Strohm Vic |
|
| December 8, 2014 |
CFN / CareFusion Corporation 425 - Merger Prospectus - 425 425 FILED BY CAREFUSION CORP. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14A-12 OF THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: CAREFUSION CORP COMMISSION FILE NO. 333-199830 BECTON DICKINSON AND CAREFUSION ANNOUNCE DATE OF SPECIAL MEETING IN PROPOSED MERGER Franklin Lakes, NJ and San Diego, CA (December 8, 2014) – Becton, Dickinson and Company |
|
| December 8, 2014 |
BDX / Becton Dickinson & Co. 425 - Merger Prospectus - 425 425 FILED BY BECTON, DICKINSON AND COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14A-12 OF THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: CAREFUSION CORP COMMISSION FILE NO. |
|
| November 25, 2014 |
BDX / Becton Dickinson & Co. 425 - Merger Prospectus - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of the earliest event reported): November 25, 2014 (November 19, 2014) BECTON, DICKINSON AND COMPANY (Exact name of registrant as specified in its charter) New Jersey 001-4802 22-0760120 (State or other |
|
| November 25, 2014 |
EX-99.1 2 d826777dex991.htm EX-99.1 Exhibit 99.1 BD Contact: Monique N. Dolecki, Investor Relations 201-847-5378 [email protected] CareFusion Contacts: Media: Kristen Cardillo (858) 617-2317 [email protected] Investors: Jim Mazzola (858) 617-1203 [email protected] BECTON DICKINSON AND CAREFUSION ANNOUNCE EXPIRATION OF HSR ACT WAITING PERIOD IN PROPOSED TRANSACTION Frankl |
|
| November 24, 2014 |
BDX / Becton Dickinson & Co. 425 - Merger Prospectus - 425 425 1 d826926d425.htm 425 FILED BY BECTON, DICKINSON AND COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14A-12 OF THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: CAREFUSION CORP COMMISSION FILE NO. 001-34273 The following communication was made available by Becton, Dickinson and Company on November 24, 2014. Integration FAQs November 24, 2014 A |
|
| November 20, 2014 |
BDX / Becton Dickinson & Co. 425 - Merger Prospectus - 425 425 FILED BY BECTON, DICKINSON AND COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14A-12 OF THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: CAREFUSION CORP COMMISSION FILE NO. |
|
| November 19, 2014 |
BDX / Becton Dickinson & Co. 425 - Merger Prospectus - FORM 425 425 1 d824567d425.htm FORM 425 FILED BY BECTON, DICKINSON AND COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14A-12 OF THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: CAREFUSION CORP COMMISSION FILE NO. 001-34273 The following Fourth Quarter and Full-Year Results for Fiscal Year of 2014 and Fiscal Year 2015 Guidance communication was made avail |
|
| November 18, 2014 |
BDX / Becton Dickinson & Co. 425 - Merger Prospectus - 425 425 FILED BY BECTON, DICKINSON AND COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14A-12 OF THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: CAREFUSION CORP COMMISSION FILE NO. |
|
| November 14, 2014 |
EX-10.1 2 d819004dex101.htm EX-10.1 Exhibit 10.1 U.S. $9,100,000,000 364-DAY BRIDGE TERM LOAN AGREEMENT Dated as of November 14, 2014 Among BECTON, DICKINSON AND COMPANY as Borrower and THE LENDERS party hereto GOLDMAN SACHS BANK USA as Administrative Agent, Sole Lead Arranger and Sole Bookrunner JPMORGAN CHASE BANK, N.A. as Co-Arranger and Syndication Agent and THE BANK OF TOKYO-MITSUBISHI UFJ, L |
|
| November 14, 2014 |
BDX / Becton Dickinson & Co. 425 - Merger Prospectus - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 14, 2014 BECTON, DICKINSON AND COMPANY (Exact name of registrant as specified in its charter) New Jersey 001-4802 22-0760120 (State or Other Jurisdiction (Commission |
|
| November 7, 2014 |
CAREFUSION CORPORATION NONQUALIFIED STOCK OPTION AGREEMENT Exhibit 10.1 CAREFUSION CORPORATION NONQUALIFIED STOCK OPTION AGREEMENT On (the “Grant Date”), CareFusion Corporation, a Delaware corporation (the “Company”), has awarded to (“Awardee”), an option (the “Option”) to purchase shares of common stock, par value $0.01 per share, of the Company (the “Shares”) for a price of per share. The Option has been granted under the CareFusion Corporation 2009 Lon |
|
| November 7, 2014 |
CAREFUSION CORPORATION PERFORMANCE STOCK UNITS AGREEMENT Exhibit 10.2 CAREFUSION CORPORATION PERFORMANCE STOCK UNITS AGREEMENT On (the “Grant Date”), CareFusion Corporation, a Delaware corporation (the “Company”), has awarded to (“Awardee”) a targeted number of (the “Target Number”) Performance Stock Units (the “Performance Stock Units” or “Award”) to be calculated and determined as discussed below. Each Performance Stock Unit will represent an unfunded |
|
| November 7, 2014 |
CAREFUSION CORPORATION RESTRICTED STOCK UNITS AGREEMENT FOR DIRECTORS EX-10.5 6 exhibit105fy15q1.htm FORM OF RESTRICTED STOCK UNITS AGREEMENT (DIRECTORS) Exhibit 10.5 CAREFUSION CORPORATION RESTRICTED STOCK UNITS AGREEMENT FOR DIRECTORS On [date of grant] (the “Grant Date”), CareFusion Corporation, a Delaware corporation (the “Company”), has awarded to [Director name] (“Awardee”), [# of Shares] Restricted Stock Units (the “Restricted Stock Units” or “Award”) and eac |
|
| November 7, 2014 |
CAREFUSION CORPORATION RESTRICTED STOCK UNITS AGREEMENT (OFFICERS) EX-10.3 4 exhibit103fy15q1.htm FORM OF RESTRICTED STOCK UNITS AGREEMENT (OFFICERS) Exhibit 10.3 CAREFUSION CORPORATION RESTRICTED STOCK UNITS AGREEMENT (OFFICERS) On (the “Grant Date”), CareFusion Corporation, a Delaware corporation (the “Company”), has awarded to (“Awardee”) Restricted Stock Units (the “Restricted Stock Units” or “Award”), representing an unfunded unsecured promise of the Company |
|
| November 7, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-34273 CareFusion Corporation (Exact na |
|
| November 7, 2014 |
Exhibit 10.6 CAREFUSION CORPORATION Executive Change in Control Severance Plan (As amended and restated effective October 5, 2014) 1. Purpose of the Plan The purpose of the Plan is to assure the Company and its Affiliates of the continued dedication, loyalty, and service of, and the availability of objective advice and counsel from, key executives of the Company in the event of a Change in Control |
|
| November 7, 2014 |
CAREFUSION CORPORATION RESTRICTED STOCK UNITS AGREEMENT Exhibit 10.4 CAREFUSION CORPORATION RESTRICTED STOCK UNITS AGREEMENT On (the ?Grant Date?), CareFusion Corporation, a Delaware corporation (the ?Company?), has awarded to (?Awardee?) Restricted Stock Units (the ?Restricted Stock Units? or ?Award?), representing an unfunded unsecured promise of the Company to deliver shares of common stock, par value $0.01 per share, of the Company (the ?Shares?) t |
|
| November 6, 2014 |
Exhibit 99.1 3750 Torrey View Ct San Diego, CA 92130 www.carefusion.com FOR IMMEDIATE RELEASE Contacts: Media: Kristen Cardillo (858) 617-2317 [email protected] Investors: Jim Mazzola (858) 617-1203 [email protected] CAREFUSION REPORTS FIRST QUARTER FISCAL 2015 RESULTS • Revenue increased 11 percent to $922 million • Diluted earnings per share (EPS) from continuing operation |
|
| November 6, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 6, 2014 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 (Commission |
|
| November 5, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 5, 2014 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26 |
|
| November 5, 2014 |
BDX / Becton Dickinson & Co. 425 - Merger Prospectus - 425 425 1 d817488d425.htm 425 FILED BY BECTON, DICKINSON AND COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14A-12 OF THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: CAREFUSION CORP COMMISSION FILE NO. 001-34273 The following is a transcript of Becton, Dickinson and Company’s earnings call held on November 4, 2014. THOMSON REUTERS STREETEVENTS EDIT |
|
| November 5, 2014 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 5, 2014 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 (Commission |
|
| October 17, 2014 |
CFN / CareFusion Corporation 425 - Merger Prospectus - 425 425 FILED BY CAREFUSION CORP. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14A-12 OF THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: CAREFUSION CORP COMMISSION FILE NO. 001-34273 The following is a transcript of a video made available to employees of CareFusion Corp. Kieran T. Gallahue (“KG”) You know, a big part of change in life and getting through |
|
| October 16, 2014 |
BDX / Becton Dickinson & Co. 425 - Merger Prospectus - 425 425 FILED BY BECTON, DICKINSON AND COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14A-12 OF THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: CAREFUSION CORP COMMISSION FILE NO. |
|
| October 10, 2014 |
CFN / CareFusion Corporation 425 - Merger Prospectus - 425 425 Filed by CareFusion Corporation Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: CareFusion Corporation (Commission File No. |
|
| October 10, 2014 |
BDX / Becton Dickinson & Co. 425 - Merger Prospectus - 425 425 FILED BY BECTON, DICKINSON AND COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14A-12 OF THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: CAREFUSION CORP COMMISSION FILE NO. |
|
| October 10, 2014 |
BDX / Becton Dickinson & Co. 425 - Merger Prospectus - 425 425 Vince Forlenza CEO and Chairman BD FILED BY BECTON, DICKINSON AND COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14A-12 OF THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: CAREFUSION CORP COMMISSION FILE NO. |
|
| October 10, 2014 |
CFN / CareFusion Corporation 425 - Merger Prospectus - 425 425 Vince Forlenza CEO and Chairman BD Filed by CareFusion Corporation Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: CareFusion Corporation (Commission File No. |
|
| October 10, 2014 |
CFN / CareFusion Corporation 425 - Merger Prospectus - 425 425 Filed by CareFusion Corporation Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: CareFusion Corporation (Commission File No. |
|
| October 10, 2014 |
CFN / CareFusion Corporation 425 - Merger Prospectus - 425 425 FILED BY CAREFUSION CORP. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14A-12 OF THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: CAREFUSION CORP COMMISSION FILE NO. 001-34273 The following is a transcript of a video made available to employees of CareFusion Corp. Dat Tran My name is Dat Tran and I’m a manager of finance and planning at CareFusion |
|
| October 8, 2014 |
CFN / CareFusion Corporation 425 - Merger Prospectus - 425 425 © 2014 CareFusion Corporation or one of its subsidiaries. All rights reserved. Filed by CareFusion Corporation Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: CareFusion Corporation (Commission File No. 001-34273) CONFIDENTIAL – for internal use only BD & CareFusion: A new direction in hea |
|
| October 8, 2014 |
BDX / Becton Dickinson & Co. 425 - Merger Prospectus - 425 425 1 d800691d425.htm 425 FILED BY BECTON, DICKINSON AND COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14A-12 OF THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: CAREFUSION CORP COMMISSION FILE NO. 001-34273 The following is a transcript of a video made available to employees of CareFusion Corp. CAREFUSION EMPLOYEES VIDEO TRANSCRIPT Kieran T. G |
|
| October 7, 2014 |
CFN / CareFusion Corporation 425 - Merger Prospectus - 425 425 Filed by CareFusion Corporation Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: CareFusion Corporation (Commission File No. |
|
| October 7, 2014 |
BDX / Becton Dickinson & Co. 425 - Merger Prospectus - 425 425 1 d800682d425.htm 425 FILED BY BECTON, DICKINSON AND COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14A-12 OF THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: CAREFUSION CORP COMMISSION FILE NO. 001-34273 The following is a transcript of a video that was made available to employees of Becton, Dickinson and Company and that may be made availa |
|
| October 7, 2014 |
BDX / Becton Dickinson & Co. 425 - Merger Prospectus - 425 425 FILED BY BECTON, DICKINSON AND COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14A-12 OF THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: CAREFUSION CORP COMMISSION FILE NO. |
|
| October 6, 2014 |
EX-99.1 Exhibit 99.1 BD Monique N. Dolecki, Investor Relations – 201-739-1837 Alyssa J. Zeff, Corporate Communications – 917-273-3685 CareFusion Jim Mazzola, Investor Relations – 858-617-1203/ 858-342-8272 Kristen Cardillo, Media – 858-617-2317/ 614-425-6502 BD TO ACQUIRE CAREFUSION FOR $12.2 BILLION Combination of Complementary Portfolios Creates Global Leader in Medication Management and Patient |
|
| October 6, 2014 |
Talking points for CareFusion Sales and Service Employees EX-99.4 Exhibit 99.4 Talking points for CareFusion Sales and Service Employees Confidential | For use in customer conversations | Do not forward, print or distribute • On Oct. 5, CareFusion and BD announced a definitive agreement for BD to acquire CareFusion, pending customary closing conditions, including regulatory and CareFusion stockholder approval. • Combined, CareFusion and BD will be a glob |
|
| October 6, 2014 |
BD and CareFusion Create Global Leader in Medication EX-99.7 Exhibit 99.7 BD and CareFusion Create Global Leader in Medication Management and Patient Safety Solutions Market Cap: $21.89 billion Revenue: $8.29 Billion1 Brands Include: Nexiva, Vacutainer, PhaSeal, FACS, Max, Cato Software Employees: 30,000 Headquarters: Franklin Lakes, NJ BD Helping all people live healthy lives Global leader in parenteral drug delivery Strong emerging markets platfor |
|
| October 6, 2014 |
EX-99.5 7 d800587dex995.htm EX-99.5 Exhibit 99.5 3750 Torrey View Ct San Diego, CA 92130 www.CareFusion.com October 5, 2014 Dear Valued Customer: Earlier today, we announced a definitive agreement for Becton Dickinson (BD) to acquire CareFusion. As you likely know, BD is a leading medical technology company with innovative solutions for improving drug delivery, enhancing the diagnosis of infectiou |
|
| October 6, 2014 |
EX-99.6 Exhibit 99.6 Email to BD Suppliers/Vendors Dear Valued [Supplier/Vendor]: I am very pleased to share with you an exciting milestone in BD’s history. Today, we announced an agreement to acquire CareFusion, a leading medical technology company with products and services that help hospitals measurably improve safety and patient care, for $12.2 billion. A copy of the press release announcing t |
|
| October 6, 2014 |
CFN / CareFusion Corporation 425 - Merger Prospectus - 425 425 Filed by CareFusion Corporation Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: CareFusion Corporation (Commission File No. |
|
| October 6, 2014 |
EX-2.1 EXHIBIT 2.1 AGREEMENT AND PLAN OF MERGER dated as of October 5, 2014 among CAREFUSION CORPORATION, BECTON, DICKINSON AND COMPANY, and GRIFFIN SUB, INC. TABLE OF CONTENTS Article 1 Definitions Section 1.01 Definitions 5 Section 1.02 Other Definitional and Interpretative Provisions 17 Article 2 THE MERGER; EFFECT ON THE CAPITAL STOCK; EXCHANGE OF CERTIFICATES Section 2.01 The Merger 18 Sectio |
|
| October 6, 2014 |
EX-99.5 Exhibit 99.5 3750 Torrey View Ct San Diego, CA 92130 www.CareFusion.com October 5, 2014 Dear Valued Customer: Earlier today, we announced a definitive agreement for Becton Dickinson (BD) to acquire CareFusion. As you likely know, BD is a leading medical technology company with innovative solutions for improving drug delivery, enhancing the diagnosis of infectious diseases and cancers, supp |
|
| October 6, 2014 |
CFN / CareFusion Corporation 425 - Merger Prospectus - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 5, 2014 CAREFUSION CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-34273 26-4123274 (State or Other Jurisdiction of Incorporation) (Co |
|
| October 6, 2014 |
BD and CareFusion Create Global Leader in Medication Management and Patient Safety Solutions EX-99.7 Exhibit 99.7 BD and CareFusion Create Global Leader in Medication Management and Patient Safety Solutions » Market Cap: $21.89 billion » Revenue: $8.29 Billion1 » Brands Include: Nexiva, Vacutainer, PhaSeal, FACS, Max, Cato Software » Employees: 30,000 » Headquarters: Franklin Lakes, NJ CareFusion +I » Market Cap: $9.22 billion » Revenue: $3.84 Billion1 » Brands Include: Alaris®, Pyxis®, C |
|
| October 6, 2014 |
EX-99.3 Exhibit 99.3 E-mail to Employees with Letter and Town Hall/Conference Call Invite Subject: BD Announces Agreement to Acquire CareFusion Dear BD Associates: I am very pleased to share with you an exciting milestone in BD’s history. Today, we announced an agreement to acquire CareFusion, a leading medical technology company with products and services that help hospitals measurably improve sa |
|
| October 6, 2014 |
EX-2.1 EXHIBIT 2.1 AGREEMENT AND PLAN OF MERGER dated as of October 5, 2014 among CAREFUSION CORPORATION, BECTON, DICKINSON AND COMPANY, and GRIFFIN SUB, INC. TABLE OF CONTENTS Article 1 Definitions Section 1.01 Definitions 5 Section 1.02 Other Definitional and Interpretative Provisions 17 Article 2 THE MERGER; EFFECT ON THE CAPITAL STOCK; EXCHANGE OF CERTIFICATES Section 2.01 The Merger 18 Sectio |
|
| October 6, 2014 |
BDX / Becton Dickinson & Co. 425 - Merger Prospectus - 425 425 FILED BY BECTON, DICKINSON AND COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14A-12 OF THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: CAREFUSION CORP COMMISSION FILE NO. |
|
| October 6, 2014 |
EX-99.6 BD & CareFusion: A new direction in healthcare NAME Title Date Exhibit 99.6 © 2014 CareFusion Corporation or one of its subsidiaries. All rights reserved. Aligned purpose To touch the life of every patient around the world. Helping all people live healthy lives © 2014 CareFusion Corporation or one of its subsidiaries. All rights reserved. ~ $700 million combined spend ~$12 billion combined |
|
| October 6, 2014 |
EX-99.6 BD & CareFusion: A new direction in healthcare NAME Title Date Exhibit 99.6 © 2014 CareFusion Corporation or one of its subsidiaries. All rights reserved. Aligned purpose To touch the life of every patient around the world. Helping all people live healthy lives © 2014 CareFusion Corporation or one of its subsidiaries. All rights reserved. ~ $700 million combined spend ~$12 billion combined |
|
| October 6, 2014 |
EX-10.1 3 d800483dex101.htm EX-10.1 Exhibit 10.1 GOLDMAN SACHS BANK USA GOLDMAN SACHS LENDING PARTNERS LLC 200 West Street New York, New York 10282-2198 PERSONAL AND CONFIDENTIAL October 5, 2014 Becton, Dickinson and Company 1 Becton Drive Franklin Lakes, NJ 07417 Attention: Christopher Reidy CFO and Executive VP of Administration Project Griffin Commitment Letter Ladies and Gentlemen: Goldman Sac |
|
| October 6, 2014 |
Talking points for CareFusion Sales and Service Employees EX-99.4 Exhibit 99.4 Talking points for CareFusion Sales and Service Employees Confidential | For use in customer conversations | Do not forward, print or distribute • On Oct. 5, CareFusion and BD announced a definitive agreement for BD to acquire CareFusion, pending customary closing conditions, including regulatory and CareFusion stockholder approval. • Combined, CareFusion and BD will be a glob |
|
| October 6, 2014 |
EX-99.1 Exhibit 99.1 BD Monique N. Dolecki, Investor Relations – 201-739-1837 Alyssa J. Zeff, Corporate Communications – 917-273-3685 CareFusion Jim Mazzola, Investor Relations – 858-617-1203/ 858-342-8272 Kristen Cardillo, Media – 858-617-2317/ 614-425-6502 BD TO ACQUIRE CAREFUSION FOR $12.2 BILLION Combination of Complementary Portfolios Creates Global Leader in Medication Management and Patient |
|
| October 6, 2014 |
EX-2.1 EXHIBIT 2.1 AGREEMENT AND PLAN OF MERGER dated as of October 5, 2014 among CAREFUSION CORPORATION, BECTON, DICKINSON AND COMPANY, and GRIFFIN SUB, INC. TABLE OF CONTENTS Article 1 Definitions Section 1.01 Definitions 5 Section 1.02 Other Definitional and Interpretative Provisions 17 Article 2 THE MERGER; EFFECT ON THE CAPITAL STOCK; EXCHANGE OF CERTIFICATES Section 2.01 The Merger 18 Sectio |
|
| October 6, 2014 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 5, 2014 CAREFUSION CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-34273 26-4123274 (State or Other Jurisdiction of Incorporation) (Co |
|
| October 6, 2014 |
Exhibit 99.5 E-mail to Customers/Distributors Dear Valued [BD Customer/Healthcare Provider]: I am very pleased to share with you an exciting milestone in BD’s history. Today, we announced an agreement to acquire CareFusion, a leading medical technology company with products and services that help hospitals measurably improve safety and patient care, for $12.2 billion. A copy of the press release a |
|
| October 6, 2014 |
CFN / CareFusion Corporation 425 - Merger Prospectus - 425 425 Filed by CareFusion Corporation Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: CareFusion Corporation (Commission File No. |
|
| October 6, 2014 |
CFN / CareFusion Corporation 425 - Merger Prospectus - 425 425 Filed by CareFusion Corporation Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: CareFusion Corporation (Commission File No. |
|
| October 6, 2014 |
EX-99.2 A Leader in Medication Management and Patient Safety October 6th, 2014 Exhibit 99.2 2 IMPORTANT INFORMATION FOR INVESTORS In connection with the proposed transaction, BD will file with the SEC a registration statement on Form S–4 that will constitute a prospectus of BD and include a proxy statement of CareFusion. BD and CareFusion also plan to file other relevant documents with the SEC reg |
|
| October 6, 2014 |
EX-99.3 Exhibit 99.3 October 5, 2014 Kieran Gallahue Chairman and CEO This is an internal communication intended for all CareFusion employees. Please do not forward or discuss this message outside of the company. Today’s announcement I wanted to be the first to let you know about an announcement we just made outlining BD’s intent to acquire CareFusion. This news is bittersweet because I’m proud of |
|
| October 6, 2014 |
EX-99.1 Exhibit 99.1 BD Monique N. Dolecki, Investor Relations – 201-739-1837 Alyssa J. Zeff, Corporate Communications – 917-273-3685 CareFusion Jim Mazzola, Investor Relations – 858-617-1203/ 858-342-8272 Kristen Cardillo, Media – 858-617-2317/ 614-425-6502 BD TO ACQUIRE CAREFUSION FOR $12.2 BILLION Combination of Complementary Portfolios Creates Global Leader in Medication Management and Patient |
|
| October 6, 2014 |
EX-99.2 A Leader in Medication Management and Patient Safety October 6th, 2014 Exhibit 99.2 2 IMPORTANT INFORMATION FOR INVESTORS In connection with the proposed transaction, BD will file with the SEC a registration statement on Form S–4 that will constitute a prospectus of BD and include a proxy statement of CareFusion. BD and CareFusion also plan to file other relevant documents with the SEC reg |
|
| October 6, 2014 |
EX-99.4 Exhibit 99.4 Homepage image: Homepage headline - BD Announces Agreement to Acquire CareFusion Homepage subhead – Accelerates BD’s transition from product-focused company to customer-centric provider of healthcare solutions. Article copy: Today, BD announced an agreement to acquire CareFusion, a leading medical technology company with products and services that help hospitals measurably imp |
|
| October 6, 2014 |
BDX / Becton Dickinson & Co. 425 - Merger Prospectus - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of the earliest event reported): October 6, 2014 (October 5, 2014) BECTON, DICKINSON AND COMPANY (Exact name of registrant as specified in its charter) New Jersey 001-4802 22-0760120 (State or other juri |
|
| October 6, 2014 |
BD and CareFusion Create Global Leader in Medication EX-99.7 Exhibit 99.7 BD and CareFusion Create Global Leader in Medication Management and Patient Safety Solutions Market Cap: $21.89 billion Revenue: $8.29 Billion1 Brands Include: Nexiva, Vacutainer, PhaSeal, FACS, Max, Cato Software Employees: 30,000 Headquarters: Franklin Lakes, NJ BD Helping all people live healthy lives Global leader in parenteral drug delivery Strong emerging markets platfor |
|
| October 6, 2014 |
EX-99.2 4 d800587dex992.htm EX-99.2 A Leader in Medication Management and Patient Safety October 6th, 2014 Exhibit 99.2 2 IMPORTANT INFORMATION FOR INVESTORS In connection with the proposed transaction, BD will file with the SEC a registration statement on Form S–4 that will constitute a prospectus of BD and include a proxy statement of CareFusion. BD and CareFusion also plan to file other relevan |
|
| October 6, 2014 |
EX-99.3 5 d800587dex993.htm EX-99.3 Exhibit 99.3 October 5, 2014 Kieran Gallahue Chairman and CEO This is an internal communication intended for all CareFusion employees. Please do not forward or discuss this message outside of the company. Today’s announcement I wanted to be the first to let you know about an announcement we just made outlining BD’s intent to acquire CareFusion. This news is bitt |
|
| September 25, 2014 |
CFN / CareFusion Corporation DEF 14A - - DEF 14A DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| September 25, 2014 |
CFN / CareFusion Corporation DEFA14A - - DEFA14A DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| August 11, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2014 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-34273 CareFusion |
|
| August 11, 2014 |
Subsidiaries of CareFusion Corporation Exhibit 21.1 Subsidiaries of CareFusion Corporation Name of Subsidiary Jurisdiction of Formation CareFusion Australia 316 Pty Limited Australia CareFusion Austria 322 GmbH Austria CareFusion D.R. 203 Ltd. Bermuda Intermed Equipamento M?dico Hospitalar Ltda. Brazil STAR - Servicos de Assistencia Tecnica A Equipamento Medico Hospitalar Ltda. Brazil Angus Medical Inc. Canada CareFusion Canada 307 ULC |
|
| August 7, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 7, 2014 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 (Commission F |
|
| August 7, 2014 |
Exhibit 99.1 3750 Torrey View Ct San Diego, CA 92130 www.carefusion.com FOR IMMEDIATE RELEASE Contacts: Media: Troy Kirkpatrick (858) 617-2361 [email protected] Investors: Jim Mazzola (858) 617-1203 [email protected] CAREFUSION REPORTS FOURTH QUARTER AND FISCAL 2014 RESULTS • Fourth quarter revenue of $1.12 billion, up 24 percent; Fiscal 2014 revenue of $3.84 billion, up 8 p |
|
| August 7, 2014 |
ex992fy14q4a01 Fiscal 2015 Financial Guidance August 7, 2014 © 2014 CareFusion Corporation or one of its subsidiaries. |
|
| June 2, 2014 |
FORM SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 (Commission File Number) (IRS Employer Identification Number) 3750 Torrey View Court, San Diego, California 92130 (Address of P |
|
| June 2, 2014 |
EX-1.02 2 d734538dex102.htm EX-1.02 Exhibit 1.02 CareFusion Corporation Conflict Minerals Report For the reporting period from January 1, 2013 to December 31, 2013 This Conflict Minerals Report (this “Report”) of CareFusion Corporation (hereinafter referred to as “CareFusion”, “we”, “us”, “our”, “the Company” and “our Company”) has been prepared pursuant to Rule 13p-1 and Form SD (the “Rule”) prom |
|
| May 22, 2014 |
EX-4.2 Exhibit 4.2 EXECUTION VERSION CAREFUSION CORPORATION and DEUTSCHE BANK TRUST COMPANY AMERICAS, AS TRUSTEE THIRD SUPPLEMENTAL INDENTURE Dated as of May 22, 2014 To the Indenture dated as of July 21, 2009 $300,000,000 1.450% Senior Notes due 2017 $400,000,000 3.875% Senior Notes due 2024 $300,000,000 4.875% Senior Notes due 2044 TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS 1 Section 1.1 Defin |
|
| May 22, 2014 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 22, 2014 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 (Commi |
|
| May 16, 2014 |
CAREFUSION CORPORATION UNDERWRITING AGREEMENT May 15, 2014 EX-1.1 Exhibit 1.1 EXECUTION VERSION CAREFUSION CORPORATION UNDERWRITING AGREEMENT May 15, 2014 To the Representatives named in Schedule I hereto of the Underwriters named in Schedule II hereto Ladies and Gentlemen: CareFusion Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule II hereto (the “Underwriters”), acting severall |
|
| May 16, 2014 |
CAREFUSION PRICES $1 BILLION OF SENIOR UNSECURED NOTES EX-99.1 Exhibit 99.1 3750 Torrey View Ct San Diego, CA 92130 www.carefusion.com FOR IMMEDIATE RELEASE Contacts: Media: Kristen Cardillo (858) 617-2317 [email protected] Investors: Jim Mazzola (858) 617-1203 [email protected] CAREFUSION PRICES $1 BILLION OF SENIOR UNSECURED NOTES SAN DIEGO, May 15, 2014 – CareFusion Corp. (NYSE: CFN), a leading, global medical technology comp |
|
| May 16, 2014 |
Final Prospectus Supplement Table of Contents Filed Pursuant to Rule 424(b)(3) Registration Statement No. |
|
| May 16, 2014 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 15, 2014 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 (Commi |
|
| May 15, 2014 |
FWP Filed Pursuant to Rule 433 under the Securities Act of 1933 Registration Statement No. |
|
| May 15, 2014 |
Subject to Completion: Dated May 15, 2014 Preliminary Prospectus Supplement Table of Contents Filed Pursuant to Rule 424(b)(5) Registration Statement No. |
|
| May 13, 2014 |
As filed with the Securities and Exchange Commission on May 13, 2014 Registration No. |
|
| May 13, 2014 |
James F. Hinrichs Chief Financial Officer 3750 Torrey View Court San Diego, CA 92130 858-617-2192 tel. [email protected] carefusion.com May 13, 2014 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: CareFusion Corporation Request for Withdrawal of Form S-3 Registration Statement No. 333-195883 Ladies and Gentle |
|
| May 12, 2014 |
EX-12.1 Exhibit 12.1 CareFusion Corporation Ratio of Earnings to Fixed Charges Fiscal Year Ended June 30, (in millions) 9 Months Ended March 31, 2014 2013 2012 2011 2010 Pretax Income from Continuing Operations $ 359 $ 543 $ 487 $ 425 $ 345 Fixed Charges (per below) 77 96 105 109 133 Interest Capitalized — (1 ) (1 ) (3 ) (2 ) Earnings $ 436 $ 638 $ 591 $ 531 $ 476 Interest and Other Financial Char |
|
| May 12, 2014 |
EX-25.1 Exhibit 25.1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ¨ CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b)(2) DEUTSCHE BANK TRUST COMPANY AMERICAS (formerly BANKERS TRUST COMPANY) (Exact name of trustee as |
|
| May 12, 2014 |
- POST-EFFECTIVE AMENDMENT NO.3 TO FORM S-1 As filed with the Securities and Exchange Commission on May 12, 2014 Registration No. |
|
| May 12, 2014 |
As filed with the Securities and Exchange Commission on May 12, 2014 Registration No. |
|
| May 12, 2014 |
Form S-3ASR Table of Contents As filed with the Securities and Exchange Commission on May 12, 2014 Registration No. |
|
| May 7, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 7, 2014 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 (Commission File |
|
| May 7, 2014 |
Exhibit 99.1 3750 Torrey View Ct San Diego, CA 92130 www.carefusion.com FOR IMMEDIATE RELEASE Contacts: Media: Troy Kirkpatrick (858) 617-2361 [email protected] Investors: Jim Mazzola (858) 617-1203 [email protected] SUPRATIM BOSE JOINS CAREFUSION BOARD OF DIRECTORS Move Increases Size of Board to 10 Members SAN DIEGO, May 7, 2014 - CareFusion (NYSE:CFN), a leading global me |
|
| May 6, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2014 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-34273 CareFusion Corporation (Exact name o |
|
| May 5, 2014 |
Exhibit 99.1 3750 Torrey View Ct San Diego, CA 92130 www.carefusion.com FOR IMMEDIATE RELEASE Contacts: Media: Kristen Cardillo (858) 617-2317 [email protected] Investors: Jim Mazzola (858) 617-1203 [email protected] CAREFUSION REPORTS THIRD QUARTER FISCAL 2014 RESULTS • Third quarter revenue increased 7 percent to $968 million, driven by continued growth in the company’s Pr |
|
| May 5, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 5, 2014 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 (Commission File |
|
| May 5, 2014 |
ex992fy14q3 Updated Fiscal 2014 Financial Guidance May 5, 2014 © 2014 CareFusion Corporation or one of its subsidiaries. |
|
| March 24, 2014 |
Filed Pursuant to Rule 424(b)(3) Registration Statement No. 333-168555 PROSPECTUS SUPPLEMENT NO. 2 (TO PROSPECTUS DATED October 9, 2013, as updated and supplemented by Prospectus Supplement No. 1 dated November 8, 2013) CareFusion Corporation CareFusion Corporation 2009 Long-Term Incentive Plan Common Stock, Par Value $0.01 Per Share The prospectus, as updated and supplemented by Prospectus Supple |
|
| February 13, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 13, 2014 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 (Commissio |
|
| February 13, 2014 |
EX-10.1 EXHIBIT 10.1 EXECUTION COPY [Published Deal CUSIP Number: ] [Published Facility CUSIP Number: ] AMENDED AND RESTATED CREDIT AGREEMENT Dated as of February 13, 2014 among CAREFUSION CORPORATION, as the Borrower, JPMORGAN CHASE BANK, N.A. as Administrative Agent, Swing Line Lender and L/C Issuer BANK OF AMERICA, N.A., as Syndication Agent and L/C Issuer THE BANK OF TOKYO-MITSUBISHI UFJ, LTD, |
|
| February 12, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 10, 2014 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 (Commissio |
|
| February 11, 2014 |
CFN / CareFusion Corporation / VANGUARD GROUP INC Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2 )* Name of issuer: CareFusion Corp Title of Class of Securities: Common Stock CUSIP Number: 14170T101 Date of Event Which Requires Filing of this Statement: December 31, 2013 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: (X) |
|
| February 6, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2013 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-34273 CareFusion Corporation (Exact nam |
|
| February 3, 2014 |
Exhibit 99.1 3750 Torrey View Ct San Diego, CA 92130 www.carefusion.com FOR IMMEDIATE RELEASE Contacts: Media: Kristen Cardillo (858) 617-2317 [email protected] Investors: Jim Mazzola (858) 617-1203 [email protected] CAREFUSION REPORTS FIRST HALF FISCAL 2014 RESULTS • Second quarter revenue increased to $922 million, driven by continued strength in the company’s Procedural S |
|
| February 3, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 3, 2014 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 (Commission |
|
| January 23, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 23, 2014 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 (Commission |
|
| January 9, 2014 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 9, 2014 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 (Commission |
|
| January 9, 2014 |
CAREFUSION ISSUES STATEMENT ABOUT PREVIOUSLY DISCLOSED GOVERNMENT SETTLEMENT EX-99.1 Exhibit 99.1 3750 Torrey View Ct San Diego, CA 92130 www.CareFusion.com FOR IMMEDIATE RELEASE Contacts: Media: Kristen Cardillo (858) 617-2317 [email protected] Investors: Jim Mazzola (858) 617-1203 [email protected] CAREFUSION ISSUES STATEMENT ABOUT PREVIOUSLY DISCLOSED GOVERNMENT SETTLEMENT SAN DIEGO, Jan. 9, 2014 – CareFusion Corp. (NYSE: CFN) today issued the fol |
|
| December 20, 2013 |
Table of Contents Filed pursuant to Rule 424(b)(3) Registration No. 333-192752 PROSPECTUS CareFusion Corporation Offer to Exchange all Outstanding and Unregistered 3.300% Senior Notes due 2023 for 3.300% Senior Notes due 2023 Which Have been Registered Under the Securities Act This prospectus and accompanying letter of transmittal relate to our proposed offer to exchange up to $300,000,000 aggrega |
|
| December 20, 2013 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 20, 2013 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 ( |
|
| December 10, 2013 |
S-4 Table of Contents As filed with the Securities and Exchange Commission on December 10, 2013 Registration No. |
|
| December 10, 2013 |
EX-25.1 Exhibit 25.1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b)(2) DEUTSCHE BANK TRUST COMPANY AMERICAS (formerly BANKERS TRUST COMPANY) (Exact name of trustee as s |
|
| December 10, 2013 |
EX 99.2 Exhibit 99.2 CAREFUSION CORPORATION LETTER OF TRANSMITTAL OFFER TO EXCHANGE $300,000,000 AGGREGATE PRINCIPAL AMOUNT OF ITS 3.300% SENIOR NOTES DUE 2023 WHICH HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, FOR ANY AND ALL OF ITS OUTSTANDING 3.300% SENIOR NOTES DUE 2023 THE EXCHANGE OFFER WILL EXPIRE AT 5:00 P.M., NEW YORK CITY TIME, ON , 2014 (THE “EXPIRATION DATE”) UNLE |
|
| December 10, 2013 |
EX 12.1 Exhibit 12.1 CareFusion Corporation Computation of Ratio of Earnings to Fixed Charges 3 Months Ended September Fiscal Year Ended June 30, (in millions) 30, 2013 2013 2012 2011 2010 2009 Pretax Income from Continuing Operations $ 96 $ 543 $ 487 $ 425 $ 345 $ 342 Fixed Charges (per below) 26 96 105 109 133 94 Interest Capitalized — (1 ) (1 ) (3 ) (2 ) — Earnings $ 122 $ 638 $ 591 $ 531 $ 476 |
|
| December 10, 2013 |
EX 99.3 Exhibit 99.3 CAREFUSION CORPORATION OFFER TO EXCHANGE $300,000,000 AGGREGATE PRINCIPAL AMOUNT OF ITS 3.300% SENIOR NOTES DUE 2023 WHICH HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, FOR ANY AND ALL OF ITS OUTSTANDING 3.300% SENIOR NOTES DUE 2023 [ ] To Brokers, Dealers, Commercial Banks, Trust Companies and other Nominees: As described in the enclosed Prospectus, dated |
|
| December 10, 2013 |
EX 99.4 Exhibit 99.4 CAREFUSION CORPORATION OFFER TO EXCHANGE $300,000,000 AGGREGATE PRINCIPAL AMOUNT OF ITS 3.300% SENIOR NOTES DUE 2023 WHICH HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, FOR ANY AND ALL OF ITS OUTSTANDING 3.300% SENIOR NOTES DUE 2023 [ ] To Our Clients: Enclosed for your consideration are a Prospectus, dated , 20 (as the same may be amended or supplemented |
|
| November 18, 2013 |
EX-99.2 Acquisition of Vital Signs Kieran Gallahue, Chairman & CEO Jim Hinrichs, CFO November 18, 2013 Exhibit 99.2 © 2013 CareFusion Corporation or one of its subsidiaries. All rights reserved. Forward-Looking Statements and Use of Non-GAAP Financial Measures 2 © 2013 CareFusion Corporation or one of its subsidiaries. All rights reserved. “Safe Harbor” Statement under the Private Securities Litig |
|
| November 18, 2013 |
Regulation FD Disclosure, Financial Statements and Exhibits 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 18, 2013 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 (Commi |
|
| November 18, 2013 |
EX-99.1 Exhibit 99.1 3750 Torrey View Ct San Diego, CA 92130 www.carefusion.com FOR IMMEDIATE RELEASE Contacts: Media: Kristen Cardillo (858) 617-2317 [email protected] Investors: Jim Mazzola (858) 617-1203 [email protected] CAREFUSION TO ACQUIRE VITAL SIGNS DIVISION OF GE HEALTHCARE FOR $500 MILLION Acquisition creates global leader in consumable medical products for respir |
|
| November 8, 2013 |
Filed Pursuant to Rule 424(b)(3) Registration Statement No. 333-168555 PROSPECTUS SUPPLEMENT NO. 1 (TO PROSPECTUS DATED October 9, 2013) CareFusion Corporation CareFusion Corporation 2009 Long-Term Incentive Plan Common Stock, Par Value $0.01 Per Share The prospectus (the “Prospectus”), as updated and supplemented by this Prospectus Supplement, relates to the 479,347 shares of common stock that ma |
|
| November 8, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2013 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-34273 CareFusion Corporation (Exact na |
|
| November 7, 2013 |
3750 Torrey View Ct San Diego, CA 92130 www.carefusion.com FOR IMMEDIATE RELEASE Contacts: Media: Kristen Cardillo (858) 617-2317 [email protected] Investors: Jim Mazzola (858) 617-1203 [email protected] CAREFUSION REPORTS FIRST QUARTER FISCAL 2014 RESULTS •Revenue of $830 million consistent with company expectations • Diluted earnings per share (EPS) from continuing operati |
|
| November 7, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 7, 2013 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 (Commission |
|
| November 6, 2013 |
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION CAREFUSION CORPORATION Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CAREFUSION CORPORATION The present name of the corporation is CareFusion Corporation (the “Corporation”). The Corporation was incorporated under the name “Cardinal Health CMP, Inc.” by the filing of its original Certificate of Incorporation with the Secretary of State of the State of Delaware on January 14, 2009. This Amended and Res |
|
| November 6, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 6, 2013 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 (Commission |
|
| November 6, 2013 |
Exhibit 3.2 AMENDED AND RESTATED BY-LAWS OF CAREFUSION CORPORATION (a Delaware Corporation) As in effect November 6, 2013 ARTICLE I STOCKHOLDERS SECTION 1. Annual Meetings. The annual meeting of stockholders of CareFusion Corporation (the “Corporation”) for the election of directors and for the transaction of such other business as may properly come before the meeting shall be held each fiscal yea |
|
| October 9, 2013 |
424B3 Table of Contents Filed pursuant to Rule 424(b)(3) Registration No. 333-168555 PROSPECTUS 479,347 Shares CareFusion Corporation CareFusion Corporation 2009 Long-Term Incentive Plan Common Stock, Par Value $0.01 Per Share The 479,347 shares of common stock covered by this prospectus may be acquired by participants in the CareFusion Corporation 2009 Long-Term Incentive Plan, which we refer to |
|
| October 7, 2013 |
CORRESP DLA Piper LLP (US) 4365 Executive Drive, Suite 1100 San Diego, California 92121-2133 www. |
|
| September 30, 2013 |
POS AM Table of Contents As filed with the Securities and Exchange Commission on September 30, 2013 Registration No. |
|
| September 26, 2013 |
DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| September 26, 2013 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| September 6, 2013 |
PRE 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| August 9, 2013 |
CAREFUSION 303, INC. AIRCRAFT TIME SHARING AGREEMENT Exhibit 10.36 CAREFUSION 303, INC. AIRCRAFT TIME SHARING AGREEMENT This Aircraft Time Sharing Agreement (?Agreement?) by and between CareFusion 303, Inc. (?Operator?), a Delaware corporation whose address is 3750 Torrey View Court, San Diego, CA 92130 and (?User?), whose address is 3750 Torrey View Court, San Diego, CA 92130 (collectively the ?Parties?), is effective , 201 . WHEREAS, Operator has |
|
| August 9, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2013 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-34273 CareFusion |
|
| August 9, 2013 |
EX-21.1 3 d561107dex211.htm EX-21.1 Exhibit 21.1 Subsidiaries of CareFusion Corporation Name of Subsidiary Jurisdiction of Formation CareFusion Australia 316 Pty Limited Australia CareFusion Austria 322 GmbH Austria CareFusion D.R. 203 Ltd. Bermuda Intermed Equipamento Médico Hospitalar Ltda. Brazil STAR — Servicos de Assistencia Tecnica A Equipamento Medico Hospitalar Ltda. Brazil Angus Medical I |
|
| August 9, 2013 |
EX-16.1 Exhibit 16.1 August 9, 2013 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Ladies and Gentlemen: We have read Item 4.01 of Form 8-K/A dated August 9, 2013, of CareFusion Corporation and are in agreement with the statements contained in the third sentence of the first paragraph and in the second, third and fifth paragraphs on page 2 therein. We have no basis to a |
|
| August 9, 2013 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant - FORM 8-K/A Form 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 9, 2013 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001 |
|
| August 8, 2013 |
2013 CareFusion Corporation or one of its subsidiaries. All rights reserved. EX-99.2 Exhibit 99.2 © 2013 CareFusion Corporation or one of its subsidiaries. All rights reserved. Forward-Looking Statements 2 © 2013 CareFusion Corporation or one of its subsidiaries. All rights reserved. “Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: This presentation contains our fiscal 2014 financial guidance, which are forward-looking statements addressi |
|
| August 8, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 8, 2013 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 (Commission F |
|
| August 8, 2013 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 8, 2013 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 (Com |
|
| August 8, 2013 |
CAREFUSION REPORTS FOURTH QUARTER AND FISCAL 2013 RESULTS EX-99.1 2 d579512dex991.htm EX-99.1 Exhibit 99.1 3750 Torrey View Ct San Diego, CA 92130 www.CareFusion.com FOR IMMEDIATE RELEASE Contacts: Media: Troy Kirkpatrick (858) 617-2361 [email protected] Investors: Jim Mazzola (858) 617-1203 [email protected] CAREFUSION REPORTS FOURTH QUARTER AND FISCAL 2013 RESULTS • Fourth quarter revenue of $903 million in line with company expe |
|
| August 8, 2013 |
EX-99.1 Exhibit 99.1 3750 Torrey View Court San Diego, CA 92130 858.617.2000 tel. 858.617.2900 fax carefusion.com August 8, 2013 Dear Jonathan: It is with great pleasure that I confirm in writing the terms and conditions of your promotion in this employment letter (“Employment Letter”), effective August 9, 2013 (the “Effective Date”). Position: Your position will be Senior Vice President, Controll |
|
| May 29, 2013 |
EX-16.1 Exhibit 16.1 May 29, 2013 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Ladies and Gentlemen: We have read Item 4.01 of Form 8-K dated May 29, 2013, of CareFusion Corporation and are in agreement with the statements contained in the fourth sentence of the first paragraph and in the second and fourth paragraphs on page 2 therein. We have no basis to agree or dis |
|
| May 29, 2013 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant - 8-K 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 29, 2013 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 (Commission |
|
| May 10, 2013 |
424B3 Table of Contents Filed Pursuant to Rule 424(b)(3) Registration Statement No. |
|
| May 10, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2013 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-34273 CareFusion Corporation (Exact name o |
|
| May 9, 2013 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 9, 2013 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 (Commis |
|
| May 9, 2013 |
CAREFUSION REPORTS THIRD QUARTER FISCAL 2013 RESULTS EX-99.1 Exhibit 99.1 3750 Torrey View Ct San Diego, CA 92130 www.CareFusion.com FOR IMMEDIATE RELEASE Contacts: Media: Kristen Cardillo (858) 617-2317 [email protected] Investors: Jim Mazzola (858) 617-1203 [email protected] CAREFUSION REPORTS THIRD QUARTER FISCAL 2013 RESULTS • Revenue of $901 million in line with company expectations • GAAP operating margins of 15 percent |
|
| April 25, 2013 |
CAREFUSION REACHES AGREEMENT IN PRINCIPLE ON PREVIOUSLY DISCLOSED MATTER WITH FEDERAL GOVERNMENT EX-99.1 Exhibit 99.1 3750 Torrey View Ct San Diego, CA 92130 www.CareFusion.com FOR IMMEDIATE RELEASE Contacts: Media: Kristen Cardillo (858) 617-2317 [email protected] Investors: Jim Mazzola (858) 617-1203 [email protected] CAREFUSION REACHES AGREEMENT IN PRINCIPLE ON PREVIOUSLY DISCLOSED MATTER WITH FEDERAL GOVERNMENT SAN DIEGO, April 25, 2013 – CareFusion Corp. (NYSE: CFN |
|
| April 25, 2013 |
Financial Statements and Exhibits, Other Events - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 25, 2013 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware 001-34273 26-4123274 (State or Other Jurisdiction of Incorporation) (Com |
|
| April 16, 2013 |
Submission of Matters to a Vote of Security Holders Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 15, 2013 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 (Com |
|
| April 8, 2013 |
424B3 Table of Contents Filed pursuant to Rule 424(b)(3) Registration No. 333-168555 PROSPECTUS 1,470,596 Shares CareFusion Corporation CareFusion Corporation 2009 Long-Term Incentive Plan Common Stock, Par Value $0.01 Per Share The 1,470,596 shares of common stock covered by this prospectus may be acquired by participants in the CareFusion Corporation 2009 Long-Term Incentive Plan, which we refer |
|
| April 5, 2013 |
POS AM Table of Contents As filed with the Securities and Exchange Commission on April 5, 2013 Registration No. |
|
| April 5, 2013 |
Acceleration Request April 5, 2013 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Amanda Ravitz Louis Rambo Re: CareFusion Corporation Post-Effective Amendment No. 1 to Form S-3 on Form S-1 Filed February 8, 2013 File No. 333-168555 Dear Ms. Ravitz: Pursuant to Rule 461 under the Securities Act of 1933, as amended ( |
|
| April 4, 2013 |
Acceleration Request April 4, 2013 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Amanda Ravitz Louis Rambo Re: CareFusion Corporation Post-effective amendment to Form S-3 on Form S-1 Filed February 8, 2013 File No. 333-168555 Dear Ms. Ravitz: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “A |
|
| March 21, 2013 |
S-1 SEC Comment Letter Nathaniel B. Sisitsky 3750 Torrey View Court VP, Associate General Counsel, San Diego, CA 92130 Corp. Governance & Securities 858.617.5911 tel. 312.949.0759 fax [email protected] carefusion.com March 21, 2013 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Amanda Ravitz Louis Ra |
|
| March 21, 2013 |
10-K SEC Comment Letter James F. Hinrichs 3750 Torrey View Court Chief Financial Officer San Diego, CA 92130 858-617-2192 tel. [email protected] carefusion.com March 21, 2013 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Brian Cascio Kristin Lochhead Martin James Re: CareFusion Corporation Form 10-K for t |
|
| March 11, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 11, 2013 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 (Commission F |
|
| March 11, 2013 |
Exhibit 4.2 Exhibit 4.2 REGISTRATION RIGHTS AGREEMENT by and among CareFusion Corporation and J.P. Morgan Securities LLC Merrill Lynch, Pierce, Fenner & Smith Incorporated Morgan Stanley & Co. LLC Dated as of March 11, 2013 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this “Agreement”) is made and entered into as of March 11, 2013, by and among CareFusion Corporation, a Delawa |
|
| March 11, 2013 |
Exhibit 4.1 Exhibit 4.1 CAREFUSION CORPORATION and DEUTSCHE BANK TRUST COMPANY AMERICAS, AS TRUSTEE SECOND SUPPLEMENTAL INDENTURE Dated as of March 11, 2013 To the Indenture dated as of July 21, 2009 3.300% Senior Notes due 2023 TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS 1 Section 1.1 Definitions 1 Section 1.2 Other Definitions 5 ARTICLE 2 THE NOTES 6 Section 2.1 Establishment of the Notes; Form |
|
| March 6, 2013 |
Financial Statements and Exhibits, Other Events - 8-K 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 6, 2013 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 (Commissio |
|
| March 6, 2013 |
CAREFUSION ANNOUNCES PROPOSED OFFERING OF $300 MILLION SENIOR NOTES EX-99.1 Exhibit 99.1 3750 Torrey View Ct San Diego, CA 92130 www.CareFusion.com FOR IMMEDIATE RELEASE Contacts: Media: Kristen Cardillo (858) 617-2317 [email protected] Investors: Jim Mazzola (858) 617-1203 [email protected] CAREFUSION ANNOUNCES PROPOSED OFFERING OF $300 MILLION SENIOR NOTES SAN DIEGO, March 6, 2013 – CareFusion Corp. (NYSE: CFN) today announced a private of |
|
| February 28, 2013 |
- DEFINITIVE ADDITIONAL MATERIALS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| February 28, 2013 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14 |
|
| February 14, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number:3235-0145 Expires: February 28, 2009 Estimated average burden hours per response… 10.4 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* CareFusion Corporation (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 14170T101 (CUSIP Number) Decembe |
|
| February 12, 2013 |
CFN / CareFusion Corporation / VANGUARD GROUP INC Passive Investment carefusioncorp.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1 )* Name of issuer: CareFusion Corp Title of Class of Securities: Common Stock CUSIP Number: 14170T101 Date of Event Which Requires Filing of this Statement: December 31, 2012 Check the appropriate box to de |
|
| February 8, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 8, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 8, 2013 |
POS AM As filed with the Securities and Exchange Commission on February 8, 2013 Registration No. |
|
| February 7, 2013 |
CAREFUSION REPORTS FIRST HALF FISCAL 2013 RESULTS News release Exhibit 99.1 3750 Torrey View Ct San Diego, CA 92130 www.CareFusion.com FOR IMMEDIATE RELEASE Contacts: Media: Kristen Cardillo (858) 617-2317 [email protected] Investors: Jim Mazzola (858) 617-1203 [email protected] CAREFUSION REPORTS FIRST HALF FISCAL 2013 RESULTS • Second quarter revenue increased 2 percent to $909 million, driven by strength in the company’s |
|
| February 7, 2013 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 7, 2013 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 (C |
|
| February 7, 2013 |
Slide presentation Updated Fiscal 2013 Financial Guidance February 7, 2013 Exhibit 99. |
|
| January 31, 2013 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 31, 2013 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 (C |
|
| January 31, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2012 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-34273 CareFusion |
|
| January 31, 2013 |
Exhibit 21.1 Subsidiaries of CareFusion Corporation Name of Subsidiary Jurisdiction of Formation CareFusion Australia 316 Pty Ltd Australia CareFusion Austria 322 Gmbh Austria CareFusion Bermuda 224 Ltd. Bermuda CareFusion D.R. 203 Ltd. Bermuda Intermed Equipamento M?dico Hospitalar Ltda. Brazil STAR - Servicos de Assistencia Tecnica A Equipamento Medico Hospitalar Ltda. Brazil CareFusion Canada 3 |
|
| January 31, 2013 |
CAREFUSION FILES FISCAL 2012 FORM 10-K News Release Exhibit 99.1 FOR IMMEDIATE RELEASE Contacts: Media: Kristen Cardillo (858) 617-2317 [email protected] Investors: Jim Mazzola (858) 617-1203 [email protected] CAREFUSION FILES FISCAL 2012 FORM 10-K SAN DIEGO, Jan. 31, 2013 – CareFusion Corporation (NYSE: CFN) today announced that it has filed its annual report on Form 10-K for the fiscal year ended June 30, 2012. |
|
| January 31, 2013 |
Exhibit 12.1 CareFusion Corporation Ratio of Earnings to Fixed Charges Fiscal Year Ended June 30, (in millions) 2012 2011 2010 2009 2008 As Restated As Restated As Restated As Restated Pretax Income from Continuing Operations $ 487 $ 425 $ 345 $ 342 $ 406 Fixed Charges (per below) 105 109 133 94 102 Interest Capitalized (1 ) (3 ) (2 ) ? (1 ) Earnings $ 591 $ 531 $ 476 $ 436 $ 507 Interest and Othe |
|
| January 22, 2013 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) CareFusion Corporation ( NAME OF ISSUER ) COMMON STOCK (Title of Class of Securities) 14170T101 (CUSIP Number) DECEMBER 31,2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: X Rule 13d-1 (b) Rule 13d-1 (c) Rule 13d-1 (d) CUSIP No. |
|
| January 14, 2013 |
Financial Statements and Exhibits, Shareholder Director Nominations 8-K 1 d466933d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 14, 2013 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 00 |
|
| January 14, 2013 |
News release issued by CareFusion Corporation Exhibit 99.1 3750 Torrey View Ct San Diego, CA 92130 www.CareFusion.com FOR IMMEDIATE RELEASE Contacts: Media: Kristen Cardillo (858) 617-2317 [email protected] Investors: Jim Mazzola (858) 617-1203 [email protected] CAREFUSION TO REPORT SECOND QUARTER FISCAL 2013 RESULTS ON FEB. 7 Fiscal 2012 Annual Meeting Scheduled for April 1 |
|
| December 27, 2012 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 27, 2012 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 ( |
|
| December 19, 2012 |
CAREFUSION PROVIDES UPDATE ON FORM 10-K, 10-Q FILINGS EX-99.1 2 d455895dex991.htm NEWS RELEASE Exhibit 99.1 FOR IMMEDIATE RELEASE Contacts: Media: Kristen Cardillo (858) 617-2317 [email protected] Investors: Jim Mazzola (858) 617-1203 [email protected] CAREFUSION PROVIDES UPDATE ON FORM 10-K, 10-Q FILINGS SAN DIEGO, Dec. 19, 2012 – CareFusion Corporation (NYSE: CFN) said today it has completed the majority of the analysis to be |
|
| December 19, 2012 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 19, 2012 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 (Commissio |
|
| December 12, 2012 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 10, 2012 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 ( |
|
| November 8, 2012 |
CAREFUSION REPORTS PRELIMINARY FIRST QUARTER FISCAL 2013 RESULTS Provides update on Form 10-K filing News Release Issued by CareFusion Corporation Exhibit 99.1 3750 Torrey View Ct San Diego, CA 92130 www.carefusion.com FOR IMMEDIATE RELEASE Contacts: Media: Kristen Cardillo (858) 617-2317 [email protected] Investors: Jim Mazzola (858) 617-1203 [email protected] CAREFUSION REPORTS PRELIMINARY FIRST QUARTER FISCAL 2013 RESULTS Provides update on Form 10-K filing SAN DIEGO, No |
|
| November 8, 2012 |
Notification of Late Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 8, 2012 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 8, 2012 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 (C |
|
| September 14, 2012 |
CAREFUSION PROVIDES UPDATE ON FORM 10-K FILING News Release issued by CareFusion Corporation Exhibit 99.1 3750 Torrey View Ct San Diego, CA 92130 www.CareFusion.com FOR IMMEDIATE RELEASE Contacts: Media: Jim Mazzola (858) 617-1203 [email protected] Investors: Jim Mazzola (858) 617-1203 [email protected] CAREFUSION PROVIDES UPDATE ON FORM 10-K FILING SAN DIEGO, Sept. 14, 2012 – CareFusion Corp. (NYSE: CFN) today announced it h |
|
| September 14, 2012 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): September 14, 2012 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 |
|
| August 29, 2012 |
Financial Statements and Exhibits, Other Events - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 29, 2012 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 (Co |
|
| August 29, 2012 |
News Release Exhibit 99.1 3750 Torrey View Ct San Diego, CA 92130 www.CareFusion.com FOR IMMEDIATE RELEASE Contacts: Media: Troy Kirkpatrick Investors: Jim Mazzola (858) 617-2361 (858) 617-1203 [email protected] [email protected] CAREFUSION ANNOUNCES DELAY IN FORM 10-K FILING; REAFFIRMS FISCAL 2013 GUIDANCE Company to host investor call at 5 p.m. EDT SAN DIEGO, Aug. 29, 2012 |
|
| August 29, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 001-34273 CUSIP Number: 14170T 101 (Check one): x Form 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: June 30, 2012 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Tran |
|
| August 9, 2012 |
EX-99.2 3 d392842dex992.htm SLIDE PRESENTATION Q4 and Fiscal 2012 Investor/Analyst Call August 9, 2012 Exhibit 99.2 © 2012 CareFusion Corporation or one of its subsidiaries. All rights reserved. © 2012 CareFusion Corporation or one of its subsidiaries. All rights reserved. 2 Forward-Looking Statements and Other Notices to Investors statements addressing expectations, prospects, estimates and other |
|
| August 9, 2012 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 9, 2012 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 (Com |
|
| August 9, 2012 |
CAREFUSION REPORTS FOURTH QUARTER AND FISCAL 2012 RESULTS News Release Exhibit 99.1 3750 Torrey View Ct San Diego, CA 92130 www.CareFusion.com FOR IMMEDIATE RELEASE Contacts: Media: Kristen Cardillo (858) 617-2317 [email protected] Investors: Jim Mazzola (858) 617-1203 [email protected] CAREFUSION REPORTS FOURTH QUARTER AND FISCAL 2012 RESULTS • Fourth quarter revenue increased 3 percent to $968 million on strong Medical Systems re |
|
| July 2, 2012 |
Executive Severance Guidelines (as amended and restated effective July 1, 2012) CareFusion Corporation Executive Severance Guidelines Exhibit 99.8 Executive Severance Guidelines (as amended and restated effective July 1, 2012) • These amended and restated executive severance guidelines (“Guidelines”) have been approved by the Human Resources and Compensation Committee (the “Committee”) of the Board of Directors of CareFusion Corporation (the “Company”), effective as of July 1 |
|
| July 2, 2012 |
CAREFUSION CORPORATION RESTRICTED STOCK UNITS AGREEMENT (CLIFF VEST) Form of Restricted Stock Units Agreement (cliff vest) Exhibit 99.6 CAREFUSION CORPORATION RESTRICTED STOCK UNITS AGREEMENT (CLIFF VEST) On (the “Grant Date”), CareFusion Corporation, a Delaware corporation (the “Company”), has awarded to (“Awardee”) Restricted Stock Units (the “Restricted Stock Units” or “Award”), representing an unfunded unsecured promise of the Company to deliver shares of commo |
|
| July 2, 2012 |
CAREFUSION CORPORATION RESTRICTED STOCK UNITS AGREEMENT Form of Restricted Stock Units Agreement (multi-year vest) Exhibit 99.5 CAREFUSION CORPORATION RESTRICTED STOCK UNITS AGREEMENT On (the “Grant Date”), CareFusion Corporation, a Delaware corporation (the “Company”), has awarded to (“Awardee”) Restricted Stock Units (the “Restricted Stock Units” or “Award”), representing an unfunded unsecured promise of the Company to deliver shares of common stock, |
|
| July 2, 2012 |
CAREFUSION CORPORATION PERFORMANCE STOCK UNITS AGREEMENT Form of Performance Stock Units Agreement Exhibit 99.2 CAREFUSION CORPORATION PERFORMANCE STOCK UNITS AGREEMENT On (the “Grant Date”), CareFusion Corporation, a Delaware corporation (the “Company”), has awarded to (“Awardee”) a targeted number of (the “Target Number”) Performance Stock Units (the “Performance Stock Units” or “Award”) to be calculated and determined as discussed below. Each Perform |
|
| July 2, 2012 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 2, 2012 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 (Commi |
|
| July 2, 2012 |
CAREFUSION CORPORATION RESTRICTED STOCK UNITS AGREEMENT (DIRECTORS) Form of Restricted Stock Units Agreement (Directors) Exhibit 99.3 CAREFUSION CORPORATION RESTRICTED STOCK UNITS AGREEMENT (DIRECTORS) On (the “Grant Date”), CareFusion Corporation, a Delaware corporation (the “Company”), has awarded to (“Awardee”), Restricted Stock Units (the “Restricted Stock Units” or “Award”), representing an unfunded unsecured promise of the Company to deliver shares of common |
|
| July 2, 2012 |
Regulation FD Disclosure - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 2, 2012 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 (Commi |
|
| July 2, 2012 |
CareFusion Corporation Executive Change in Control Severance Plan Exhibit 99.9 CAREFUSION CORPORATION Executive Change in Control Severance Plan (As amended and restated effective July 1, 2012) 1. Purpose of the Plan The purpose of the Plan is to assure the Company and its Affiliates of the continued dedication, loyalty, and service of, and the availability of objective advice and counsel from, ke |
|
| July 2, 2012 |
CareFusion Corporation Severance Plan Exhibit 99.7 CAREFUSION CORPORATION SEVERANCE PLAN (Amended and Restated Effective July 1, 2012) TABLE OF CONTENTS Page 1. INTRODUCTION 1 2. DEFINITIONS 1 (a) “Benefits Administrative Committee” 1 (b) “Base Compensation” 1 (c) “Board” 1 (d) “Break in Service” 1 (e) “COBRA” 2 (f) “Code” 2 (g) “Company” 2 (h) “Continuous Service” 2 (i) “Date of Hire” 2 (j) “Date |
|
| July 2, 2012 |
CAREFUSION CORPORATION RESTRICTED STOCK UNITS AGREEMENT (OFFICERS) Form of Restricted Stock Units Agreement (Officers) Exhibit 99.4 CAREFUSION CORPORATION RESTRICTED STOCK UNITS AGREEMENT (OFFICERS) On (the “Grant Date”), CareFusion Corporation, a Delaware corporation (the “Company”), has awarded to (“Awardee”) Restricted Stock Units (the “Restricted Stock Units” or “Award”), representing an unfunded unsecured promise of the Company to deliver shares of common st |
|
| July 2, 2012 |
CAREFUSION CORPORATION NONQUALIFIED STOCK OPTION AGREEMENT Form of Nonqualified Stock Option Agreement Exhibit 99.1 CAREFUSION CORPORATION NONQUALIFIED STOCK OPTION AGREEMENT On (the “Grant Date”), CareFusion Corporation, a Delaware corporation (the “Company”), has awarded to (“Awardee”), an option (the “Option”) to purchase shares of common stock, par value $0.01 per share, of the Company (the “Shares”) for a price of per share. The Option has been grant |
|
| May 4, 2012 |
Computation of Ratio of Earnings to Fixed Charges Exhibit 12.1 CareFusion Corporation Ratio of Earnings to Fixed Charges Fiscal Year Ended June 30, (in millions) 9 Months Ended March 31, 2012 2011 2010 2009 2008 2007 Pretax Income from Continuing Operations $ 351 $ 418 $ 345 $ 318 $ 433 $ 177 Fixed Charges (per below) 78 106 131 94 97 84 Interest Capitalized (1 ) (3 ) (2 ) — (1 ) — Earnings $ 428 |
|
| May 4, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2012 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-34273 CareFusion Corporation (Exact name o |
|
| May 3, 2012 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 3, 2012 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 (Commis |
|
| May 3, 2012 |
2012 CareFusion Corporation or one of its subsidiaries. All rights reserved. Slide presentation © 2012 CareFusion Corporation or one of its subsidiaries. All rights reserved. Q3 and 9-Months Fiscal 2012 Investor/Analyst Call May 3, 2012 Exhibit 99.2 © 2012 CareFusion Corporation or one of its subsidiaries. All rights reserved. 2 Safe Harbor and Additional Information “Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: This presentation conta |
|
| May 3, 2012 |
CAREFUSION REPORTS THIRD QUARTER FISCAL 2012 RESULTS News release Exhibit 99.1 3750 Torrey View Ct San Diego, CA 92130 www.CareFusion.com FOR IMMEDIATE RELEASE Contacts: Media: Kristen Cardillo (858) 617-2317 [email protected] Investors: Jim Mazzola (858) 617-1203 [email protected] CAREFUSION REPORTS THIRD QUARTER FISCAL 2012 RESULTS • Revenue increased 9 percent to $919 million • GAAP diluted earnings per share (EPS) from con |
|
| April 23, 2012 |
CAREFUSION TO SELL NEURODIAGNOSTIC BUSINESS TO NATUS MEDICAL FOR $58 MILLION News Release Exhibit 99.1 3750 Torrey View Ct San Diego, CA 92130 www.CareFusion.com FOR IMMEDIATE RELEASE Contacts: Media: Kristen Cardillo (CareFusion) (858) 617-2317 [email protected] Investors: Jim Mazzola (CareFusion) (858) 617-1203 [email protected] Steven J. Murphy (Natus) (650) 802-0400 [email protected] CAREFUSION TO SELL NEURODIAGNOSTIC BUSINESS TO NATUS |
|
| April 23, 2012 |
Regulation FD Disclosure, Financial Statements and Exhibits, Material Impairments - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 23, 2012 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 (Com |
|
| April 2, 2012 |
CORRESP TO SEC James F. Hinrichs 3750 Torrey View Court Chief Financial Officer San Diego, CA 92130 858.617.2192 tel. [email protected] carefusion.com April 2, 2012 VIA EDGAR AND MESSENGER U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Brian Cascio Kristin Lochhead Gary Todd Re: CareFusion Corporation Form 10-K for |
|
| February 14, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number:3235-0145 Expires: February 28, 2009 Estimated average burden hours per response… 10.4 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* CareFusion Corporation (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 14170T101 (CUSIP Number) Decembe |
|
| February 10, 2012 |
Financial Statements and Exhibits, Other Events - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 10, 2012 CareFusion Corporation (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-34273 26-4123274 ( |
